It has been proposed that elevated levels of tissue iron increase the risk
for atherosclerosis, perhaps by favoring the formation of pro-atherogenic o
xidized LDL. Working with apoE-deficient (apoE(-/-)) mice, which do not req
uire a high-fat diet to develop atherosclerosis, we compared the effects of
standard diet (0.02% iron) or a 2% carbonyl iron diet. After 24 weeks, mic
e fed the 2% carbonyl iron diet had twice as much iron in their plasma, a n
inefold increase in bleomycin-detectable free iron in their plasma, and ten
times as much iron in their livers as control mice. Dietary iron overload
caused a modest (30%) rise in plasma triglyceride and cholesterol. Neverthe
less, this regimen did not exacerbate, but rather reduced the severity of a
therosclerosis by 50%, and it failed to elevate hepatic levels of heme oxyg
enase mRNA, which is induced by many different oxidative insults in vitro.
Moreover, hepatic levels of protein-bound dityrosine and ortho-tyrosine, tw
o markers of metal-catalyzed oxidative damage in vitro, failed to rise in i
ron-overloaded animals. Our observations suggest that elevated serum and ti
ssue levels of iron are not atherogenic in apoE(-/-) mice. Moreover, they c
all into question the hypothesis that elevated levels of tissue iron promot
e LDL oxidation and oxidative stress in vivo.